Arsani William, Director at Design Therapeutics, Inc. (DSGN), sold 780,254 shares at $5.25 ($4.1M) on 2025-08-13, disclosed to the SEC on 2025-08-14.
Open-market sale of $4.1M DSGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.25 | 217,627 | $1.1M | 27.9% |
| 2 | $5.25 | 217,627 | $1.1M | 27.9% |
| 3 | $5.25 | 345,000 | $1.8M | 44.2% |
| Total | $5.25 avg | 780,254 | $4.1M | 100% |
| Filing → |
| DSGN | BUY | 2022-03-22 | $950K | — | Filing → |
| DSGN | BUY | 2021-09-02 | $618K | — | Filing → |
| DSGN | BUY | 2021-04-01 | $14.0M | — | Filing → |